These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 32462486)

  • 1. Anti-MRSA agent discovery using Caenorhabditis elegans-based high-throughput screening.
    Kim SM; Escorbar I; Lee K; Fuchs BB; Mylonakis E; Kim W
    J Microbiol; 2020 Jun; 58(6):431-444. PubMed ID: 32462486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole animal automated platform for drug discovery against multi-drug resistant Staphylococcus aureus.
    Rajamuthiah R; Fuchs BB; Jayamani E; Kim Y; Larkins-Ford J; Conery A; Ausubel FM; Mylonakis E
    PLoS One; 2014; 9(2):e89189. PubMed ID: 24586584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of an Antimicrobial Agent Effective against Methicillin-Resistant Staphylococcus aureus Persisters Using a Fluorescence-Based Screening Strategy.
    Kim W; Conery AL; Rajamuthiah R; Fuchs BB; Ausubel FM; Mylonakis E
    PLoS One; 2015; 10(6):e0127640. PubMed ID: 26039584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Neutrally Charged Diarylurea Compound PQ401 Kills Antibiotic-Resistant and Antibiotic-Tolerant Staphylococcus aureus.
    Kim W; Zou G; Pan W; Fricke N; Faizi HA; Kim SM; Khader R; Li S; Lee K; Escorba I; Vlahovska PM; Gao H; Ausubel FM; Mylonakis E
    mBio; 2020 Jun; 11(3):. PubMed ID: 32605985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of potential anti-infectives against Staphylococcus aureus using a Caenorhabditis elegans infection model.
    Kong C; Yehye WA; Abd Rahman N; Tan MW; Nathan S
    BMC Complement Altern Med; 2014 Jan; 14():4. PubMed ID: 24393217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of antibiotic resistance, virulence gene profiles, and pathogenicity of methicillin-resistant and methicillin-susceptible Staphylococcus aureus using a Caenorhabditis elegans infection model.
    Thompson T; Brown PD
    Pathog Glob Health; 2014 Sep; 108(6):283-91. PubMed ID: 25319852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial Properties of Four Novel Hit Compounds from a Methicillin-Resistant Staphylococcus aureus-Caenorhabditis elegans High-Throughput Screen.
    Tharmalingam N; Rajmuthiah R; Kim W; Fuchs BB; Jeyamani E; Kelso MJ; Mylonakis E
    Microb Drug Resist; 2018 Jun; 24(5):666-674. PubMed ID: 29461939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on the use of C. elegans for preclinical drug discovery: screening and identifying anti-infective drugs.
    Kim W; Hendricks GL; Lee K; Mylonakis E
    Expert Opin Drug Discov; 2017 Jun; 12(6):625-633. PubMed ID: 28402221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diphenylurea derivatives for combating methicillin- and vancomycin-resistant Staphylococcus aureus.
    Eissa IH; Mohammad H; Qassem OA; Younis W; Abdelghany TM; Elshafeey A; Abd Rabo Moustafa MM; Seleem MN; Mayhoub AS
    Eur J Med Chem; 2017 Apr; 130():73-85. PubMed ID: 28249208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-throughput screening for novel anti-infectives using a C. elegans pathogenesis model.
    Conery AL; Larkins-Ford J; Ausubel FM; Kirienko NV
    Curr Protoc Chem Biol; 2014 Mar; 6(1):25-37. PubMed ID: 24652621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo activity of a novel sorafenib derivative SC5005 against MRSA.
    Chang HC; Huang YT; Chen CS; Chen YW; Huang YT; Su JC; Teng LJ; Shiau CW; Chiu HC
    J Antimicrob Chemother; 2016 Feb; 71(2):449-59. PubMed ID: 26553845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new class of synthetic retinoid antibiotics effective against bacterial persisters.
    Kim W; Zhu W; Hendricks GL; Van Tyne D; Steele AD; Keohane CE; Fricke N; Conery AL; Shen S; Pan W; Lee K; Rajamuthiah R; Fuchs BB; Vlahovska PM; Wuest WM; Gilmore MS; Gao H; Ausubel FM; Mylonakis E
    Nature; 2018 Apr; 556(7699):103-107. PubMed ID: 29590091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vitro and In Vivo Antibacterial Activity of Gliotoxin Alone and in Combination with Antibiotics against
    Esteban P; Redrado S; Comas L; Domingo MP; Millán-Lou MI; Seral C; Algarate S; Lopez C; Rezusta A; Pardo J; Arias M; Galvez EM
    Toxins (Basel); 2021 Jan; 13(2):. PubMed ID: 33498622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy with thioridazine and dicloxacillin combats meticillin-resistant Staphylococcus aureus infection in Caenorhabditis elegans.
    Poulsen MØ; Schøler L; Nielsen A; Skov MN; Kolmos HJ; Kallipolitis BH; Olsen A; Klitgaard JK
    J Med Microbiol; 2014 Sep; 63(Pt 9):1174-1180. PubMed ID: 24913562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A multicentric study on clinical characteristics and antibiotic sensitivity in children with methicillin-resistant
    Wu X; Yu H; He LY; Wang CQ; Xu HM; Zhao RQ; Jing CM; Chen YH; Chen J; Deng JK; Shi J; Lin AW; Li L; Deng HL; Cai HJ; Chen YP; Wen ZW; Yang JH; Zhang T; Xiao FF; Cao Q; Huang WC; Hao JH; Zhang CH; Huang YY; Ji XF
    Zhonghua Er Ke Za Zhi; 2020 Aug; 58(8):628-634. PubMed ID: 32842382
    [No Abstract]   [Full Text] [Related]  

  • 16. New Is Old, and Old Is New: Recent Advances in Antibiotic-Based, Antibiotic-Free and Ethnomedical Treatments against Methicillin-Resistant Staphylococcus aureus Wound Infections.
    Dou JL; Jiang YW; Xie JQ; Zhang XG
    Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27120596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-infective drug development for MRSA.
    Daniel A
    Methods Mol Biol; 2014; 1085():311-31. PubMed ID: 24085703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community-associated and healthcare-associated methicillin-resistant Staphylococcus aureus virulence toward Caenorhabditis elegans compared.
    Day SR; Moore CM; Kundzins JR; Sifri CD
    Virulence; 2012 Nov; 3(7):576-82. PubMed ID: 23076331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The herbal-derived honokiol and magnolol enhances immune response to infection with methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant S. aureus (MRSA).
    Choi EJ; Kim HI; Kim JA; Jun SY; Kang SH; Park DJ; Son SJ; Kim Y; Shin OS
    Appl Microbiol Biotechnol; 2015 May; 99(10):4387-96. PubMed ID: 25586586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic susceptibility patterns of
    Kengne M; Fotsing O; Ndomgue T; Nwobegahay JM
    Pan Afr Med J; 2019; 32():103. PubMed ID: 31223393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.